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The Human Rho-GEF Trio and Its Target GTPase
RhoG Are Involved in the NGF Pathway,
Leading to Neurite Outgrowth
whose length was superior to at least two body lengths.
Expression of GEFD1 promoted lamellipodia formation
and cell spreading, but never induced neurite formation
(Figure 1A). Expression of the constitutive form of RhoG
(RhoGV12), whose wild-type counterpart is the direct
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1919 Route de Mende target of GEFD1 in vitro and in fibroblasts [9], induced
the same type of structures. In contrast, expression of34293 Montpellier Ce´dex 5
France the RhoA-specific GEFD2 induced cell retraction, as did
the activated form of its GTPase target (Figure 1A).
Interestingly, PC12 cells expressing the full-length
Trio protein (GFP-Trio) developed very long neurites inSummary
more than 50% of the transfected cells (Figures 1B and
1C). As previously observed [4], the wild-type form ofRho-GTPases control a wide range of physiological
processes by regulating actin cytoskeleton dynamics RhoG also induced the extension of neurites (Figures
1B and 1C). All together, these observations suggest[1]. Numerous studies on neuronal cell lines have es-
tablished that Rac, Cdc42, and RhoG activate neurite that the activity of the Trio Rho-GEF domains is highly
regulated in the context of the full-length protein to allowextension, while RhoA mediates neurite retraction [2–
5]. Guanine nucleotide exchange factors (GEFs) acti- Trio-induced neurite outgrowth.
vate Rho-GTPases by accelerating GDP/GTP ex-
change [6]. Trio displays two Rho-GEF domains, Trio Is Localized in the Lamellipodia Structure
GEFD1, activating the Rac pathway via RhoG, and of the Growth Cone
GEFD2, acting on RhoA, and contains numerous sig- Analysis of phase-contrast time-lapse microscopy of
naling motifs whose contribution to Trio function has GFP-Trio-expressing PC12 cells demonstrated that
not yet been investigated [7–9]. Genetic analyses in Trio-expressing growth cones possessed very dynamic
Drosophila and in Caenorhabditis elegans indicate structures such as filopodia and lamellipodia (Figure
that Trio is involved in axon guidance and cell motility 2A). Moreover, as shown by fluorescence time-lapse
via a GEFD1-dependent process, suggesting that the microscopy of the same cell, GFP-Trio was enriched
activity of its Rho-GEFs is strictly regulated [10–14]. in these actin-rich structures, indicating that Trio was
Here, we show that human Trio induces neurite out- present in the motile growth cone (Figure 2A). To better
growth in PC12 cells in a GEFD1-dependent manner. visualize the localization of Trio, we used immunofluo-
Interestingly, the spectrin repeats and the SH3-1 do- rescence images of GFP-Trio, actin, and tubulin, ac-
main of Trio are essential for GEFD1-mediated neurite quired at different Z planes for volume rendering of the
outgrowth, revealing an unexpected role for these mo- image using Imaris software. The volume reconstruction
tifs in Trio function. Moreover, we demonstrate that of the growth cone clearly showed that Trio was present
Trio-induced neurite outgrowth is mediated by the inside the F-actin-rich lamellipodia structure found at
GEFD1-dependent activation of RhoG, previously the tip of the growth cone (Figure 2B).
shown to be part of the NGF (nerve growth factor)
pathway [4]. The expression of different Trio mutants
TrioGEFD1 Cooperates with the Spectrin Repeatsinterferes with NGF-induced neurite outgrowth, sug-
and the SH3-1 Domain to Promote Efficientgesting that Trio may be an upstream regulator of
Neurite OutgrowthRhoG in this pathway. In addition, we show that Trio
In order to determine the contribution of the numerousprotein accumulates under NGF stimulation. Thus, Trio
signaling motifs of Trio in Trio-induced neurite out-is the first identified Rho-GEF involved in the NGF-
growth, we designed different deletion constructs (sum-differentiation signaling.
marized in Figure 3A) and tested the effect of their ex-
pression on PC12 cell morphology. Their expression andResults
their correct size were checked by Western blot analysis
(data not shown). Interestingly, deletion of the kinaseHuman Trio Induces Neurite Outgrowth
domain (GFP-Trio 1-2308) or deletion of the kinase andin PC12 Cells
the GEFD2 domains (GFP-Trio 1-1813) did not affect theAs Trio potentially activates antagonistic pathways in
capacity of Trio to induce neurite outgrowth (compareneuronal cells via its two Rho-GEF domains, we investi-
Figures 3B, lanes 1 and 3, and 1C). Similarly, the deletiongated the role of Trio in neurite outgrowth in PC12 cells.
of the N-terminal part of Trio (GFP-Trio 250-2308) hadWe first determined the effects on PC12 cell morphology
little incidence on Trio-induced neurite outgrowth. Weof the two Trio Rho-GEFs when expressed individually.
then tested the effect of a double point mutation in thePC12 cells were transfected with different Trio cDNA
DH1 domain Q1368A and L1376E (GFP-TrioAE), whichconstructs and were scored for the presence of neurites
drastically reduced GEFD1 in vitro exchange activity
toward RhoG (data not shown). Indeed, the presence1Correspondence: debant@crbm.cnrs-mop.fr
2 These authors contributed equally to this work. of this double mutation in the DH1 domain completely
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Figure 1. Full-Length Trio Induces Neurite
Outgrowth in PC12 Cells
(A) PC12 cells were transfected with (A and
B) HA-TrioGEFD1, (E and F) HA-TrioGEFD2,
(C and D) GFP-RhoGV12, or (G and H) GFP-
RhoAV14. After 48 hr, cells were fixed and
permeabilized as described [18]. (C and G)
Expression of the GFP-GTPases was de-
tected directly, (A and E) whereas Trio con-
structs were detected using the anti-HA
12CA5 mAb, followed by incubation with
FITC-conjugated anti-mouse IgG. Filamen-
tous actin was stained with rhodamine-conju-
gated phalloidin (B, D, F, and H). The scale
bar represents 5 m.
(B) PC12 cells were transfected as indicated
and treated as described in (A). Expression
of (A) GFP-Trio and of (C) GFP-RhoGwt was
detected directly, and (B and D) filamentous
actin was stained with rhodamine-conju-
gated phalloidin. The scale bar represents
5 m.
(C) Quantification of neurite outgrowth.
Transfected cells were scored for the pres-
ence of neurites whose length was superior
to at least two body lengths. Results are ex-
pressed as the percentage of cells with neu-
rites versus the total number of transfected
cells. At least 100 cells were counted in each
experiment, and data are the means  stan-
dard errors of at least 3 independent experi-
ments.
abolished Trio function (Figure 3B, lane 7). Furthermore, GTPase and efficiently inhibits GEFD1 activity on actin
cytoskeleton remodeling in fibroblasts [9]. Both RhoGdeletion of the SH3-1 domain (GFP-Trio 1-1579) or pro-
gressive deletions of the spectrin repeats (GFP-Trio 696- mutants very efficiently inhibited Trio-induced neurite
outgrowth (Figure 3C), suggesting that Trio may stimu-1813, GFP-Trio 926-1813) significantly abrogated Trio
effect on neuronal morphology (Figure 3B, lanes 4–6). late neurite outgrowth through the activation of RhoG.
However, since TrioGEFD1 activates both RhoG andConsistently, mutation in the TrioSH3-1 domain of a
conserved tryptophane residue that has been shown Rac in vitro, we cannot rule out the possibility that Trio
also acts directly through the GTPase Rac to promoteelsewhere to be crucial for binding SH3 ligands [15]
strongly affected Trio-induced neurite outgrowth neurite outgrowth. Expression of the dominant-negative
form of Rac (RacN17) partially inhibited Trio effect on(W1636P, GFP-TrioP, Figure 3B, lane 8). Furthermore,
cells expressing the triple Trio mutant (GFP-TrioAEP) neuronal morphology, while expression of Cdc42N17
only mildly affected Trio effect (Figure 3C). This observa-were unable to produce any neurites, as expected (Fig-
ure 3B, lane 9). All together, these data point to an tion is reminiscent of RhoG-induced neurite outgrowth,
which had been previously shown to be more affectedunexpected role of TrioSH3-1 and the spectrin repeats
in modulating the GEFD1-dependent effect of Trio on by RacN17 than by Cdc42N17 [4]. In addition, Trio effect
on neuronal morphology was completely blocked byneuronal morphology.
dominant-negative forms of the RhoG-specific effectors
kinectin and RhoGIP122 (Figure 3C), which do not bindThe GTPase RhoG Mediates Trio-Induced
to Rac or Cdc42 GTPases and thus specifically interfereNeurite Formation
with the RhoG pathway [9, 16]. Thus, Trio likely stimu-We then investigated which GTPase mediated Trio-
lates neurite outgrowth through the activation of RhoG,induced neurite outgrowth in PC12 cells. Since RhoGwt
and not through the direct activation of Rac.induced neurite outgrowth in those cells, by acting up-
stream of Rac and Cdc42 [4], and since RhoG is a target
of GEFD1 [9], we investigated whether it could mediate Trio Protein Accumulates in Response to NGF
(Nerve Growth Factor) StimulationTrio effect on neuronal morphology. We coexpressed
Trio with two dominant-negative forms of RhoG, of PC12 Cells
Since RhoG mRNA has been shown to be induced byRhoGN17 and RhoGA37 (Figure 3C). The latter mutant
is impaired in its binding to known effectors of the NGF [4], we checked whether Trio expression was also
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Figure 2. Trio Is Localized in the Lamelli-
podia Structure of the Growth Cone
(A) Growth cone morphology of GFP-Trio-
expressing PC12 cells was monitored by
video microscopy. Cell images were captured
both in epifluorescence and phase contrast
every 90 s. A representative selection of the
images is shown here. See the Supplemen-
tary Material available with this article online
for movies.
(B) Volume rendering of growth cones from
Trio-expressing PC12 cells. After 48 hr of ex-
pression, cells were fixed using the DSP fixa-
tion protocol as described [19]. A stack of 19
optical sections (0.2 m) was restored using
the Huygens system. Restored images were
processed with Imaris 2.7 for volume render-
ing. See the Supplementary Material for de-
tails regarding image acquisition.
modulated in response to NGF. The endogenous Trio Trio could also contribute to the NGF pathway. For that
purpose, we tested the capacity of different Trio mutantsprotein was present at a weak level in the soluble fraction
of serum-starved and proliferative PC12 cells (Figure to interfere with the NGF pathway. Expression of the
GFP-TrioAE or GFP-TrioP mutants partially inhibited4A and data not shown). The amount of Trio increased
several fold after 7 hr of NGF stimulation (Figure 4A). NGF-induced neurite outgrowth. Interestingly, GFP-
TrioAEP and the N-terminal part of Trio containing theHowever, no significant induction was observed at the
mRNA level, as analyzed by quantitative PCR (data not spectrin repeats (GFP-Trio 1-1203) very efficiently
blocked NGF-induced neurite formation (Figure 4B). Allshown), suggesting that NGF likely regulates Trio ex-
pression at a posttranscriptional level. together, these data suggest that Trio participates in
NGF-differentiation signaling as an upstream regulator
of RhoG.Trio Mutants Interfere with the
NGF-Differentiation Pathway
RhoG has been recently proposed to be a mediator of Discussion
NGF-induced neurite outgrowth [4]. Indeed, RhoGN17,
RhoGA37, and the deletion mutant of the RhoG-specific The Rac and RhoA GTPases have antagonistic effects
on neuronal morphology. Rac activation leads to neuri-effector kinectin efficiently blocked NGF-induced neu-
rite outgrowth (Figure 4B). We thus investigated whether togenesis, while RhoA activation promotes cell retrac-
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Figure 3. TrioGEFD1 Cooperates with the
Spectrin Repeats and the SH3-1 Domain to
Promote an Efficient Neurite Outgrowth Me-
diated by the GTPase RhoG
(A) A schematic representation of the differ-
ent Trio constructs used in this study.
(B) Effect of the different Trio deletion or point
mutants on the morphology of PC12 cells.
PC12 cells were transfected with the different
constructs as indicated (the numbering refers
to [A]) and were treated as described in Figure
1. Quantification of transfected cells dis-
playing neurites whose length was superior
to at least two body lengths was done as in
Figure 1C.
(C) PC12 cells were transfected with GFP-Trio
1-2308 alone or in combination with different
HA-tagged cDNA constructs as indicated.
Cells were then treated as described in Figure
1. Quantification of transfected cells dis-
playing neurites whose length was superior
to at least two body lengths was done as in
Figure 1C.
tion and prevents NGF-differentiation signaling [5]. We ing motifs that may participate in the regulation of Trio
Rho-GEF activity. We show here that the C-terminalshow here that the human Rho-GEF Trio efficiently in-
duces neurite outgrowth in PC12 cells by a process that kinase domain of Trio is not required for neurite out-
growth, consistent with the finding that Trio orthologsis dependent only on GEFD1 activity and not on GEFD2,
which is consistent with the data obtained with Trio involved in axon guidance do not contain a similar kinase
domain. While GEFD1 activity is required for Trio-orthologs [10]. These observations indicate that the ac-
tivity of the Trio Rho-GEFs is strictly regulated. In the induced neurite outgrowth, expression of GEFD1 alone
does not lead to neuronal differentiation, but rather pro-case of GEFD2, the expression of this RhoA-specific
GEF alone induces cell retraction in PC12 cells, showing motes the formation of a large lamellipodia. This obser-
vation indicates that the activity of GEFD1 must bethat it is functional in intact cells. Thus, it is likely that
the GEFD2 activity is negatively regulated in the context strictly regulated in the context of the full-length protein.
Using deletion and point mutants of Trio, we show thatof the full-length protein, and that it may have no major
function in neurite outgrowth of PC12 cells. However, the GEFD1-dependent neurite outgrowth induced by
Trio requires the presence of the spectrin repeats andmutations in Drosophila Trio lead to overextension of
the dendrites in the mushroom bodies (MBs), and, inter- the SH3-1 domain, revealing an unexpected role for
these motifs in Trio function. These domains could, forestingly, this phenotype is also observed in RhoA mu-
tants [11, 17]. Thus, Trio may regulate dendritic growth example, target Trio to an appropriate specific location
within the cell. However, their exact role in the regulationvia its RhoA-specific GEF domain.
Trio is a complex protein displaying numerous signal- of Trio activity is still unclear.
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(data not shown), suggesting that the inhibition of Trio
signaling by RhoGA37 does not result from Trio titration;
and, more importantly, fragments of RhoG-specific ef-
fectors, which interfere only with the RhoG pathway,
efficiently inhibit Trio effect, strongly suggesting that
Rac is not the direct target of Trio. The fact that RacN17
partially inhibits Trio-induced neurite outgrowth can be
explained by the fact that RhoG is an upstream activator
of Rac [4, 18].
RhoG has been proposed to participate in NGF-differ-
entiation signaling, and its mRNA expression is induced
by NGF treatment of PC12 cells. The Rho-GEF responsi-
ble for the activation of RhoG in this system has not
been identified. Here, we present evidence that Trio may
be one mediator of RhoG activation in response to the
NGF-differentiation signal. We show that Trio protein
accumulates under NGF treatment, providing a strong
link between Trio and the NGF-signaling pathway. More-
over, expression of different dominant-negative mutants
of Trio significantly blocks NGF neurite outgrowth.
These observations together with the fact that RhoG is
likely to be the direct target of Trio strongly suggest that
Trio acts as an upstream regulator of RhoG in the NGF-
differentiation pathway. Finally, Trio is the first identified
Rho-GEF regulated by the NGF-triggered differentiation
signal.
Supplementary Material
Supplementary Material including the Experimental Pro-
cedures and the movies corresponding to the selection
presented in Figure 2A is available at http://images.
cellpress.com/supmat/supmatin.htm.
Figure 4. Trio Is Involved in the NGF-Differentiation Pathway
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